Clinical Trial Update: POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic Schizophrenia [Phase 2]

View source ↗

Summary

A Phase 2 proof-of-concept trial evaluated adding pipamperone to stable risperidone or paliperidone therapy in chronic schizophrenia (also relevant to schizoaff…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• PALIPERIDONE (paliperidone)
• Pipamperone (pipamperone)
• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: PharmaNeuroBoost N.V. | Conditions: Chronic Schizophrenia, Schizoaffective Disorder | Phase 2 | Status: COMPLETED